2010
DOI: 10.1038/nm.2087
|View full text |Cite
|
Sign up to set email alerts
|

Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

31
839
3
3

Year Published

2011
2011
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 976 publications
(897 citation statements)
references
References 31 publications
31
839
3
3
Order By: Relevance
“…Because of the lack of direct contact with live microbes, it has long been presumed that the microbiota does not influence these systemic defences. We now know that this assumption is incorrect and that the production and function of cells that constitute systemic defences is greatly influenced by the microbiota 29, 30, 39, 66, 67, 68…”
Section: Host Resistance To Systemic Infection and The Microbiotamentioning
confidence: 99%
See 1 more Smart Citation
“…Because of the lack of direct contact with live microbes, it has long been presumed that the microbiota does not influence these systemic defences. We now know that this assumption is incorrect and that the production and function of cells that constitute systemic defences is greatly influenced by the microbiota 29, 30, 39, 66, 67, 68…”
Section: Host Resistance To Systemic Infection and The Microbiotamentioning
confidence: 99%
“…The resulting agglomeration of immune cells and structures helps to manage and contain the microbiota at the mucosa 23, 24. The microbiota also drives the maturation of systemic immunity beyond the confines of the mucosa, including in major immune tissues such as the bone marrow and spleen 25, 26, 27, 28, 29, 30. The importance of host–microbiota interactions for our health has been highlighted by clinical studies and work with animal models demonstrating that microbiota dysbiosis is associated with diseases and immune dysfunctions in both intestinal and extra‐intestinal tissues.…”
Section: Introductionmentioning
confidence: 99%
“…For example, dental bacteria can cause episodic bacteremia and release LPS into the circulation and may also seed biofilm formation on orthopaedic implants [29,77,78]. Moreover, there is extensive evidence that PAMPs can translocate from the gastrointestinal tract to distant organs, including the bone marrow, and systemically prime the innate immune system in the absence of infection [14,18,25,28,42,63,70,71,84,101,115]. This translocation of PAMPs from the gut can be increased by minor surgical procedures, such as colonoscopy, a high-fat diet, or even a single high-fat meal [3,14,52,71,84].…”
Section: Toll-like Receptorsmentioning
confidence: 99%
“…The local effects of the PAMPs can also include increased corrosion of titanium surfaces, which in turn can increase PAMP binding to the surface [6]. Alternatively, gut-derived PAMPs could induce chronic low-level inflammation systemically [14,18,25,28,42,52,63,70,71,84,101,115], as appears to occur in the synovium during rheumatoid arthritis [12,106]. In this regard, it has recently been proposed that systemic low-level inflammation may contribute to aseptic loosening [81].…”
Section: Toll-like Receptorsmentioning
confidence: 99%
“…L'impact du microbiote intestinal n'est pas limité à l'intestin, il s'exerce également à l'échelle systémique des organismes hôtes. Il régule en effet la maturation du système immunitaire [5,6], la croissance post-natale [7,8], et peut même influencer l'activité cérébrale [9,10,48] (➜). Chez l'homme, des perturbations du microbiote intestinal sont associées à une grande variété de pathologies d'ordre métabolique, immunitaire ou même cognitif [11,12].…”
unclassified